The South Korean government this Saturday announced a new agreement with Pfizer to purchase 40 million more doses of its COVID-19 vaccine, bringing the doses purchased so far to 192 million in a country of about 52 million people.
According to the Bloomberg news agency, the country has already reserved enough doses to immunize 99 million people.
Health Minister Kwon Deok Cheol, who met twice with Pfizer officials this month, told the media that “the additional contract will allow South Korea to get vaccines against the coronavirus in a more stable manner,” according to the Yonhap News Agency.
The Asian country has so far made agreements with five pharmaceutical companies, including AstraZeneca, Moderna, Janssen and Novavax. In addition, you have access to the COVAX mechanism, which is promoted by the World Health Organization (WHO).
The South Korean authorities started the vaccination campaign in late February. However, only 2.2 million doses have been administered to date, which is 4.3 percent of the population, according to government figures. Only 0.2 percent completed the vaccination plan.
Authorities reported 785 new cases of COVID-19 this Saturday, bringing the confirmed positive results since the pandemic started at 118,243. At least 1,812 patients have died, one more than on Friday, according to the South Korean Disease Control and Prevention Agency.